Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Biopolis, Singapore, Singapore.
School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Front Immunol. 2019 Jun 5;10:1227. doi: 10.3389/fimmu.2019.01227. eCollection 2019.
Despite continuous efforts, the century-old goal of eradicating malaria still remains. Multiple control interventions need to be in place simultaneously to achieve this goal. In addition to effective control measures, drug therapies and insecticides, vaccines are critical to reduce mortality and morbidity. Hence, there are numerous studies investigating various malaria vaccine candidates. Most of the malaria vaccine candidates are subunit vaccines. However, they have shown limited efficacy in Phase II and III studies. To date, only whole parasite formulations have been shown to induce sterile immunity in human. In this article, we review and discuss the recent developments in vaccination with sporozoites and the mechanisms of protection involved.
尽管不断努力,消除疟疾这一具有百年历史的目标仍然遥不可及。要实现这一目标,需要同时采取多种控制干预措施。除了有效的控制措施、药物治疗和杀虫剂外,疫苗对于降低死亡率和发病率至关重要。因此,有许多研究正在探索各种疟疾疫苗候选物。大多数疟疾疫苗候选物是亚单位疫苗。然而,它们在 II 期和 III 期研究中的效果有限。迄今为止,只有全寄生虫制剂被证明可在人体中诱导无菌免疫。本文综述并讨论了疟原虫疫苗接种的最新进展及其涉及的保护机制。